MedPath
TGA Approval

EVIPLERA tenofovir disoproxil fumarate 300 mg /emtricitabine 200 mg /rilpivirine (as HCl) 25 mg tablet bottle (176537)

176537

EVIPLERA tenofovir disoproxil fumarate 300 mg /emtricitabine 200 mg /rilpivirine (as HCl) 25 mg tablet bottle

Gilead Sciences Pty Ltd

January 30, 2012

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/bff2991cee38e36a73a4b38a7d4be5fb.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/edcda25ea9590b8cce01e952feecf6f3.pdf

Active Ingredients

emtricitabine

rilpivirine hydrochloride

tenofovir disoproxil fumarate

© Copyright 2025. All Rights Reserved by MedPath
EVIPLERA tenofovir disoproxil fumarate 300 mg /emtricitabine 200 mg /rilpivirine (as HCl) 25 mg tablet bottle (176537) - TGA 批准文号 | MedPath